Frequently Asked Questions
The market is segmented based on Global Craniomaxillofacial Devices Market, By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, and Bone Graft Substitute System), Implant Type (Standard Implants, and Customized/Patient-specific Implants), Location (Internal Fixators, and External Fixators), Materials (Metals, Bio absorbable Materials, Ceramics, and Polymers), Application (Trauma Reconstruction Surgery, Dental Surgery, Neurosurgery and ENT, Orthognathic Surgery, and Plastic Surgery), Resorbability (Resorbable Fixators, and Non-Resorbable Fixators), Device Type (Reconstruction Surgery Devices, and Trauma Surgery Devices), End-Use (Hospitals, and Ambulatory Surgery Centers) - Industry Trends and Forecast to 2031.
.
The Global Craniomaxilofacial Devices Market size was valued at USD 1.83 USD Billion in 2023.
The Global Craniomaxilofacial Devices Market is projected to grow at a CAGR of 7.65% during the forecast period of 2024 to 2031.
The major players operating in the market include Johnson & Johnson Services, Inc. (U.S.), Stryker (U.S.), Medartis AG (Switzerland), Zimmer Biomet (U.S.), B. Braun Melsungen AG (Germany), Invibio Ltd. (U.K.), Antibe Therapeutics Inc. (Canada), GENERAL ELECTRIC (U.S.), Matrix Surgical U.S. (U.S.), Summit Medical Group (U.S.), Integra LifeSciences (U.S.), CONMED Corporation (U.S.), KLS Martin Group (Germany), Medtronic (U.S.), TMJ Concepts (U.S.), OsteoMed (U.S.), W. L. Gore & Associates, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.
